Study in Subjects Suspected of Having CAD Undergoing VISIPAQUE-enhanced CCTA as Part of Their Routine Medical Care
Completed
Conditions studied: Coronary Artery Disease (CAD)
In brief
To assess prognostic value of CCTA examination in subjects who undergo CCTA as part of their medical care when compared to a standard of truth, i.e. subject outcomes during each follow-up period.
Key facts
- Study ID
- NCT00783302
- Run by
- GE Healthcare
- People needed
- 885
- Starts
- 2008-09-01
- Expected to finish
- 2011-04-01
- Last updated by the study team
- 2014-12-11
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- The subject is over 18 years old, exhibits chest pain syndrome and is scheduled to undergo a VISIPAQUE-enhanced CCTA examination for one of the following reasons:- Intermediate pre-test probability of CAD.
- An uninterruptible/equivocal stress test (exercise, perfusion, or stress echo).
Where it is running
- GE Healthcare — Princeton, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.